Electrophysiology
DOACs vs warfarin, bleeding risk, and stroke prevention
Emerging evidence with 100 primary claims
Specific, answerable questions in this area — each with its own synthesized evidence and consensus. Open one to see the forest plot, source trials, and how the consensus has changed over time.
Does rivaroxaban vs apixaban improve Cardiac Output in Venous Thromboembolism?
Low Certainty+ Favors benefitrivaroxaban vs apixaban · Cardiac Output
Does sirolimus vs placebo improve outcomes in At high risk for bleeding?
Low Certainty+ Favors benefitsirolimus vs placebo · Major Bleeding
Does dabigatran vs warfarin improve outcomes in HEART-VALVE, MECHANICAL?
Low Certainty+ Favors benefitdabigatran vs warfarin · Ventricular Arrhythmia
Does warfarin vs placebo improve outcomes in Hemorrhage?
Low Certainty− Favors harmwarfarin vs placebo · All-Cause Mortality
Does rivaroxaban vs apixaban improve outcomes?
Low Certainty− Favors harmrivaroxaban vs apixaban · Cardiac Index
Does apixaban vs placebo improve outcomes?
Low Certainty− Favors harmapixaban vs placebo · Ventricular Arrhythmia
Does tirofiban vs aspirin improve outcomes in Stroke?
Low Certainty− Favors harmtirofiban vs aspirin · Stroke Hospitalization
Anticoagulation in AF (also known as DOAC AF, NOAC atrial fibrillation, AF anticoagulation). DOACs vs warfarin, bleeding risk, and stroke prevention
Synapse tracks 7 specific clinical questions in Anticoagulation in AF, each synthesized independently from its own trial evidence. They include: "Does rivaroxaban vs apixaban improve Cardiac Output in Venous Thromboembolism?"; "Does sirolimus vs placebo improve outcomes in At high risk for bleeding?"; "Does dabigatran vs warfarin improve outcomes in HEART-VALVE, MECHANICAL?"; "Does warfarin vs placebo improve outcomes in Hemorrhage?"; "Does rivaroxaban vs apixaban improve outcomes?".
As of 2026-06-25, the scientific consensus on Anticoagulation in AF is emerging. Emerging evidence with 100 primary claims Based on 100 analyzed claims across Synapse's enriched corpus, the evidence shows.
This evidence brief synthesizes Synapse's enriched cardiology corpus; cite as synapsesocial.com/topics/69b0a30cb42209bc31dca33a.
Deterministic synthesis from Synapse's enriched corpus — 127 words. No AI-generated novel content; every figure is sourced from the underlying paper, guideline, or trial record linked on this page.
Explore every Anticoagulation in AF paper on Synapse with AI-enriched clinical evidence, PICO analysis, and methodology classification.
Search Anticoagulation in AF papersPowered by Synapse — AI-enriched analysis of 600,000+ peer-reviewed papers